Butane

Butane

SCHEMBL4463544

CC(C)(C)OC(C)(C)C.CCCC.COC

nearest known ligand 0.38

Full drug profile on Sugi Atlas →

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.38
TSHR P16473 1/20 0.35
TDP1 Q9NUW8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Butane SCHEMBL3799640 0.93 TSHR (0.33) ALDH1A1TSHRTDP1
Methoxymethane SCHEMBL8323899 0.84 ALDH1A1 (0.50) ALDH1A1TSHRTDP1
Propane SCHEMBL1683354 0.81 TSHR (0.36) ALDH1A1TSHRTDP1
Hexane SCHEMBL7875362 0.79 TSHR (0.47) ALDH1A1TSHR
SCHEMBL27338597 0.79 ALDH1A1 (0.38) ALDH1A1TSHRTDP1
Hexane SCHEMBL1554946 0.76 TSHR (0.44) ALDH1A1TSHR
Pentane SCHEMBL12271939 0.76 TSHR (0.47) ALDH1A1TSHRTDP1
Dodecane SCHEMBL20299936 0.76 TSHR (0.53) ALDH1A1TSHR
Heptane SCHEMBL7940831 0.76 TSHR (0.53) ALDH1A1TSHR
Ethylene Glycol SCHEMBL2878574 0.76 ALDH1A1 (0.35) ALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8642802-B2 Process for the preparation of halogenated benzoic acid derivatives HOFFMANN-LA ROCHE INC. (US) 2014-02-04 US disclosed
EP-2310349-B1 PROCESS FOR THE PREPARATION OF HALOGENATED BENZOIC ACID DERIVATIVES HOFFMANN LA ROCHE (CH) 2013-04-24 EP disclosed
US-20120330055-A1 PROCESS FOR THE PREPARATION OF HALOGENATED BENZOIC ACID DERIVATIVES BACHMANN STEPHAN (CH) 2012-12-27 US disclosed
US-8329939-B2 Process for the preparation of halogenated benzoic acid derivatives HOFFMANN-LA ROCHE INC. (US) 2012-12-11 US disclosed
US-20120130121-A1 PROCESS FOR THE PREPARATION OF HALOGENATED BENZOIC ACID DERIVATIVES BACHMANN STEPHAN (CH) 2012-05-24 US disclosed
US-20090306423-A1 PROCESS FOR THE PREPARATION OF HALOGENATED BENZOIC ACID DERIVATIVES HOFFMANN-LA ROCHE, INC. 2009-12-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090306423-A1 PROCESS FOR THE PREPARATION OF HALOGENATED BENZOIC ACID DERIVATIVES CYP2F1, CYP3A5, GABRA5 ALDH1A1 294/4885TSHR 1718/4885TDP1 4059/4885
US-20120330055-A1 PROCESS FOR THE PREPARATION OF HALOGENATED BENZOIC ACID DERIVATIVES CYP2F1, GABRA5, CYP3A5 ALDH1A1 283/4885TSHR 1746/4885TDP1 4066/4885
US-20120130121-A1 PROCESS FOR THE PREPARATION OF HALOGENATED BENZOIC ACID DERIVATIVES CYP2F1, GABRA5, CYP3A5 ALDH1A1 283/4885TSHR 1746/4885TDP1 4066/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.